Breast Cancer Screening Market to Grow at a CAGR of 4.8% to reach US$ 6,209.25 Million from 2019 to 2027

Breast Cancer Screening Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Test Type (Blood Marker tests, Imaging Test, Genetic Test, Immunohistochemistry Test); End User (Hospitals, Diagnostic Centers, Cancer Institutes, Research Laboratories), and Geography

Publication Month: Apr 2020 | Report Code: TIPRE00009796 | No. of Pages: 156 | Category: Medical Device | Status: Published
Covid

The global breast cancer screening market is expected to reach US$ 6,209.25 Mn by 2027 from US$ 4,638.63 Mn in 2019; it is estimated to grow at a CAGR of 4.8% from 2020 to 2027.

 

Breast cancer is the most common and widely occurring type of cancer among women; it develops in breast tissues, usually in the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It can also occur in the fatty tissue or fibrous connective tissue within breasts. Early diagnosis of breast cancer is important as it may prevent the condition from becoming critical and ensure a successful curable treatment. The screening methods for the diagnosis of breast cancer include mammography, magnetic resonance imaging (MRI), ultrasound, and others. The foremost goal of screening is to detect disease at its earliest and most treatable stage. The screening procedures identify the early signs of cancer, even before the symptoms begin to show.

 

Lucrative Regional Breast cancer screening Markets

Lucrative Regional Breast cancer screening Markets

Get more information on this report :


 

Market Insights

Globally Growing Breast Cancer Prevalence

Breast cancer is among the prime causes of deaths in the world, and it is profoundly affecting the quality of life. Thus, it acts as a burden on society if not diagnosed and treated on time. As per the estimations by the American Cancer Society, breast cancer is the most common type of cancer in the US as it caused morbidity in ~234,087 people and lead to 41,904 deaths in 2018. Further, ~276,480 new cases are expected in the country in 2020. As per the Globocan 2019 report, in Germany, the total number of breast cancer cases in 2018 was 71,888, and around the disease lead to ~19,376 deaths in that year. Further, as per the Globocan report, in 2018, there were ~367,900 new cases of breast cancer and 97,972 deaths due to the same in China. In India, NGOs, government agencies, and charity organizations are emphasizing on breast cancer awareness among population to promote early detection, provide comprehensive treatment module, and extend support for breast cancer management. Such initiatives are a result of the increasing prevalence of this type of cancer in the country. As per the Globocan report estimation, in 2018, India reported ~162,468 new breast cancer cases and 87,090 deaths due to the same. Such growing prevalence of breast cancer in different regions around the world is raising the global demand for the screening devices for the same.

 

Test Type-Based Market Insights

The breast cancer screening market, by product type, is segmented into blood marker tests, imaging test, genetic test, immunohistochemistry test. The imaging test segment held the largest share of the market in 2019, and it is also anticipated to register the highest CAGR in the market during the forecast period.

 

Global Breast Cancer screening Market, by Product Type– 2018 and 2027

Global Breast Cancer screening Market, by Product Type– 2018 and 2027

Get more information on this report :


 

End-User-Based Insights

On the basis of end user, the breast cancer screening market has been segmented into hospitals, diagnostic centers, cancer institutes, and research laboratories. The hospitals segment held the largest share of the market in 2019, whereas the diagnostic centers segment is estimated to register the highest CAGR in the market during the forecast period.

 

Strategic Insights

Product launches and approvals is a commonly adopted strategy by companies in the breast cancer screening market to expand their footprint worldwide and meet the growing demand by enlarging their product portfolios. They also adopt the strategy of expansion to enlarge customer base across the world, which also permits them to maintain their brand name globally. For instance, in June 2017, Siemens Healthineers received Food and Drug Administration (FDA) approval of product namely syngo.via VB20 which is likely to use for for Molecular Imaging (MI) from Siemens Healthineers — a new release of the company’s established intelligent visualization software for multi-modality imaging.

 

Breast Cancer Screening Market – By Product Type

  • Blood Marker Test
  • Imaging Test
  • Genetic Test
  • Immunohistochemistry Test


Breast Cancer Screening Market – By Application

  • Diagnostic Centers
  • Hospitals
  • Research Laboratories
  • Cancer Institutes


Breast Cancer Screening – By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

 

Company Profiles

  • Koninklijke Philips N.V..
  • Hologic, Inc.
  • BD
  • Myriad Genetics, Inc. Siemens Healthineers AG Exact sciences corporation
  • Oncocyte corporation
  • POC Medical Systems Danaher
  • General Electric Company

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Breast Cancer Screening Market – By Test Type

1.3.2        Global Breast Cancer Screening Market – By End User

1.3.3        Global Breast Cancer Screening Market – By Geography

2.             Breast Cancer Screening Market – Key Takeaways

2.1       Global Breast Cancer Screening Market Overview

2.2       Global Breast Cancer Screening Market, By Geography (US$ Million)

2.3       Global Breast Cancer Screening Market- Leading Country Markets (US$ Million)

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Breast Cancer Screening – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America – PEST Analysis

4.2.2        Europe – PEST Analysis

4.2.3        Asia Pacific – PEST Analysis

4.2.4        Middle East and Africa (MEA) – PEST Analysis

4.2.5        South and Central America (SCAM) – PEST Analysis

4.3       Expert Opinion

5.             Breast Cancer Screening– Key Market Dynamics

5.1       Key Market Drivers

5.1.1        Globally Growing Breast Cancer Prevalence

5.1.2        Increasing Investments in Breast Cancer Management

5.2       Key Market Restraints

5.2.1        High Cost of Breast Cancer Screening

5.3       Key Market Opportunities

5.3.1        Emerging Markets in Developing Countries

5.4       Future Trends

5.4.1        Consistent Launch of New Screening Products

5.5       Impact Analysis

6.             Breast Cancer Screening Market – Global Analysis

6.1       Global Breast Cancer Screening Market Revenue Forecast and Analysis

6.2       Global Breast cancer screening Market, By Geography - Forecast and Analysis

6.3       Market Positioning of Key Players

7.             Breast Cancer Screening Market Analysis – By Test Type

7.1       Overview

7.2       Breast Cancer Screening Market Revenue Share, by Test Type (2019 and 2027)

7.3       Blood Marker Test

7.3.1        Overview

7.3.2        Blood Marker Tests:Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

7.5       Imaging Test

7.5.1        Overview

7.5.2        Imaging Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)

7.6       Genetic Test

7.6.1        Overview

7.6.2        Genetic Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

7.7       Immunohistochemistry Test

7.7.1        Overview

7.7.2        Immunohistochemistry Test: Breast Cancer Screening Market – Revenue and Forecast to 2027  (US$ Million)

8.             Breast Cancer Screening Market – By End User

8.1       Overview

8.2       Breast Cancer Screening Market, by End-User, 2019 and 2027 (%)

8.3       Hospitals

8.3.1        Overview

8.3.2        Hospitals: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

8.4       Diagnostics Centers

8.4.1        Overview

8.4.2        Diagnostic Centers: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

8.5       Research Laboratories

8.5.1        Overview

8.6       Research Laboratories: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

8.7       Cancer Institutes

8.7.1        Overview

8.8       Cancer Institutes: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

9.             Breast Cancer Screening Market – Geographic Analysis

9.1       North America: Breast Cancer Screening Market

9.1.1        Overview

9.1.2        North America: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        North America: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.1.4        North America: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.1.5        North America: Breast Cancer Screening Market, by Country, 2019 & 2027 (%)

9.1.6        US: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1      US: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2      US: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.1.6.3      US: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.1.7        Canada: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1      Canada: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2      Canada: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.1.7.3      Canada: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.1.8        Mexico: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1      Mexico: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2      Mexico: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.1.8.3      Mexico: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.2       Europe: Breast Cancer Screening Market

9.2.1        Overview

9.2.2        Europe: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)

9.2.3        Europe: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.2.4        Europe: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.2.5        Europe: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)

9.2.6        Germany: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.2.6.1      Germany: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.2.6.2      Germany: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.2.6.3      Germany: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.2.7        UK: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.2.7.1      UK: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.2.7.2      UK: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.2.7.3      UK: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.2.8        France: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.2.8.1      France: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.2.8.2      France: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.2.8.3      France: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.2.9        Spain: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.2.9.1      Spain: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.2.9.2      Spain: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.2.9.3      Spain: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.2.10     Italy: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.2.10.1    Italy: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.2.10.2    Italy: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.2.10.3    Italy: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.3       Asia Pacific: Breast Cancer Screening Market

9.3.1        Overview

9.3.2        Asia Pacific: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)

9.3.3        Asia Pacific: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.3.4        Asia Pacific: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.3.5        Asia Pacific: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)

9.3.6        China: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.3.6.1      China: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.3.6.2      China: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.3.6.3      China: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.3.7        Japan: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.3.7.1      Japan: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.3.7.2      Japan: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.3.7.3      Japan: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.3.8        India: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.3.8.1      India: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.3.8.2      India: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.3.8.3      India: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.3.9        South Korea: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.3.9.1      South Korea: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.3.9.2      South Korea: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.3.9.3      South Korea: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.3.10     Australia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.3.10.1    Australia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.3.10.2    Australia: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.3.10.3    Australia: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.4       Middle East & Africa: Breast Cancer Screening Market

9.4.1        Overview

9.4.2        Middle East & Africa: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)

9.4.3        Middle East & Africa: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.4.4        Middle East & Africa: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.4.5        Middle East & Africa: Breast Cancer Screening Market Share by Country – 2019 & 2027, (%)

9.4.6        Saudi Arabia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.4.6.1      Saudi Arabia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.4.6.2      Saudi Arabia: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.4.6.3      Saudi Arabia: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.4.7        UAE: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.4.7.1      UAE: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.4.7.2      UAE: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.4.7.3      UAE: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.4.8        South Africa: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

9.4.8.1      South Africa: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.4.8.2      South Africa: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.4.8.3      South Africa: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.5       South and Central America: Breast Cancer Screening Market

9.5.1        Overview

9.5.2        South and Central America: Breast Cancer Screening Market - Revenue and Forecast to 2027  (US$ Million)

9.5.3        South and Central America: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.5.4        South and Central America: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.5.5        South and Central America: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)

9.5.6        Brazil: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.5.6.1      Brazil: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.5.6.2      Brazil: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.5.6.3      Brazil: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

9.5.7        Argentina: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.5.7.1      Argentina: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

9.5.7.2      Argentina: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)

9.5.7.3      Argentina: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)

10.          Impact Of COVID-19 Pandemic On Global Breast Cancer Screening Market

10.1    North America: Impact Assessment of COVID-19 Pandemic

10.2    Europe: Impact Assessment Of COVID-19 Pandemic

10.3    Asia-Pacific: Impact Assessment of COVID-19 Pandemic

10.4    Rest of the World: Impact Assessment of COVID-19 Pandemic

11.          Breast Cancer Screening Market –Industry Landscape

11.1    Overview

11.2    Growth Strategies in The Breast Cancer Screening Market, 2016-2020

11.3    Inorganic Growth Strategies

11.3.1     Overview

11.4    Organic Growth Strategies

11.4.1     Overview

12.          Breast Cancer Screening Market – Key Company Profiles

12.1    General Electric Company

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2    Siemens Healthineers AG

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3    Exact Sciences Corporation

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4    Koninklijke Philips N.V.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5    Hologic, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6    BD

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7    Myriad Genetics, Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8    Oncocyte Corporation

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9    Danaher

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10 POC Medical Systems

12.10.1   Key Facts

12.10.2   Business Description

12.10.3   Products and Services

12.10.4   Financial Overview

12.10.5   SWOT Analysis

12.10.6   Key Developments

13.          Appendix

13.1    About the Insight Partners

13.2    Glossary of Terms


LIST OF TABLES

Table 1.             North America Breast Cancer Screening Market, by Test Type– Revenue and Forecast to 2027 (USD Million)

Table 2.             North America Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 3.             US Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             US Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 5.             Canada Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             Canada Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7.             Mexico Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             Mexico Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 9.             Europe Breast Cancer Screening Market, by Test Type– Revenue and Forecast to 2027 (USD Million)

Table 10.          Europe Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 11.          Germany Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          Germany Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.          UK Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          UK Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 15.          France Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 16.          France Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 17.          Spain Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 18.          Spain Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 19.          Italy Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 20.          Italy Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 21.          Asia Pacific Breast Cancer Screening Market, by Test Type– Revenue and Forecast to 2027 (USD Million)

Table 22.          Asia Pacific Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 23.          China Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 24.          China Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 25.          Japan Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 26.          Japan Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 27.          IndiaBreast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 28.          IndiaBreast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 29.          South Korea Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 30.          South Korea Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 31.          Australia Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 32.          Australia Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 33.          Middle East & Africa Breast Cancer Screening Market, by Test Type– Revenue and Forecast to 2027 (USD Million)

Table 34.          Middle East & Africa Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 35.          Saudi Arabia Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 36.          Saudi Arabia Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 37.          UAE Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 38.          UAE Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 39.          South Africa Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 40.          South Africa Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 41.          South and Central America Breast Cancer Screening Market, by Test Type– Revenue and Forecast to 2027  (USD Million)

Table 42.          South and Central America Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 43.          Brazil Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 44.          Brazil Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 45.          Argentina Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)

Table 46.          Argentina Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 47.          Recent Inorganic Growth Strategies In The Breast Cancer Screening Market

Table 48.          Recent Organic Growth Strategies In The Breast Cancer Screening Market

Table 49.          Glossary of Terms, Breast Cancer Screening Market

 


LIST OF FIGURES

Figure 1.           Breast Cancer Screening Market Segmentation

Figure 2.           Breast Cancer Screening Segmentation, By Region

Figure 3.           Imaging Tests Held Largest Share of Breast Cancer Screening Market

Figure 4.           Asia Pacific  to Register Remarkable CAGR in Market During Forecast Period

Figure 5.           North America PEST Analysis

Figure 6.           Europe PEST Analysis

Figure 7.           Asia Pacific PEST Analysis

Figure 8.           Middle East and Africa (MEA) PEST Analysis

Figure 9.           South and Central America (SCAM) PEST Analysis

Figure 10.        Breast Cancer Screening Market Impact Analysis Of Driver And Restraints

Figure 11.        Global Breast Cancer Screening Market – Revenue Forecast and Analysis – 2019- 2027

Figure 12.        Global Breast cancer screening Market – By Geography Forecast And Analysis – 2019- 2027

Figure 13.        Market Positioning Of Key Players In Global Breast cancer screening Market

Figure 14.        Breast Cancer Screening Market Revenue Share, by Test Type (2019 and 2027)

Figure 15.        Blood Marker Tests: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Imaging Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Genetic Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Immunohistochemistry Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Breast Cancer Screening Market, by End-User, 2019 and 2027 (%)

Figure 20.        Hospitals: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Diagnostic Centers: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Research Laboratories: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Cancer Institutes: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        North America: Breast Cancer Screening Market, by Key Country – Revenue (2019) (USD Million)

Figure 25.        North America Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)

Figure 26.        North America: Breast Cancer Screening Market, by Country, 2019 & 2027 (%)

Figure 27.        US: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Canada: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Mexico: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Europe: Breast Cancer Screening Market, by Key Country – Revenue (2019) (USD Million)

Figure 31.        Europe Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)

Figure 32.        Europe: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)

Figure 33.        Germany: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.        UK: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        France: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 36.        Spain: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 37.        Italy: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 38.        Asia Pacific: Breast Cancer Screening Market, by Key Country – Revenue (2019) (USD Million)

Figure 39.        Asia Pacific Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)

Figure 40.        China: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 41.        Japan: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 42.        India: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 43.        South Korea: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 44.        Australia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 45.        Middle East & Africa: Breast Cancer Screening Market, by Key Country – Revenue (2019) (USD Million)

Figure 46.        Middle East & Africa Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)

Figure 47.        Middle East & Africa: Breast Cancer Screening Market Share by Country – 2019 & 2027, (%)

Figure 48.        Saudi Arabia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 49.        UAE: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)

Figure 50.        South Africa: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 51.        South and Central America: Breast Cancer Screening Market, by Key Country – Revenue (2019) (USD Million)

Figure 52.        South and Central America Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)

Figure 53.        South and Central America: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)

Figure 54.        Brazil: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 55.        Argentina: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)

Figure 56.        Impact of COVID-19 Pandemic In North American Country Markets

Figure 57.        Impact of COVID-19 Pandemic In European Country Markets

Figure 58.        Impact of COVID-19 Pandemic In Asia Pacific Country Markets

Figure 59.        Impact Of COVID-19 Pandemic In Rest of the World Countries Market

Figure 60.        Growth Strategies in TheBreast Cancer Screening Market, 2016-2020

The List of Companies - Breast Cancer Screening Market

  1. Koninklijke Philips N.V..
  2. HOLOGIC, INC.
  3. BD
  4. MYRIAD GENETICS, INC.
  5. SIEMENS HEALTHCARE GMBH
  6. Exact Sciences Corporation
  7. ONCOCYTE CORPORATION
  8. POC MEDICAL SYSTEMS
  9. Danaher
  10. GENERAL ELECTRIC
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the breast cancer screening market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global breast cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

TIPRE00009796
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

The diagnosis of breast cancer is done through breast cancer screening methods such as mammography, magnetic resonance imaging (MRI), ultrasound, and others. Screening examinations are tests performed for early diagnosis of the disease. The foremost goal of screening is to detect disease at its earliest and most treatable stage.

The growth of the market is attributed to some key driving factors such as increasing number of breast cancer cases, growing geriatric population and rising adoption of technology for screening purpose. However, high cost of screening method and bassinet on global business due to coronavirus pandemic are expected to restraint the growth of the market during the forecast years.

The North American region holds the largest market for the breast cancer screening. The United States held the largest market for breast cancer screening mean market and is expected to grow due to factors such as increasing number of rising in prevalence of breast cancer, growing developments for screening and imaging process by the companies and others.

Pricing